Myocardial fibrosis blunts nitric oxide synthase-related preload reserve in human dilated cardiomyopathy
- 1 January 2003
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 284 (1) , H10-H16
- https://doi.org/10.1152/ajpheart.00401.2002
Abstract
The purpose of the study was to investigate interactions between myocardial nitric oxide synthase (NOS) and myocardial fibrosis, both of which determine left ventricular (LV) preload reserve in patients with nonischemic dilated cardiomyopathy (DCM). In previous animal experiments, chronic inhibition of NOS induced myocardial fibrosis and limited LV preload reserve. Twenty-eight DCM patients underwent LV catheterization, balloon caval occlusions (BCO; n = 8), intracoronary substance P infusion ( n = 8), and procurement of LV endomyocardial biopsies for determinations of collagen volume fraction (CVF), of gene expression of NOS2, NOS3, heme oxygenase (HO)-1, and TNF-α, and of NOS2 protein. CVF was unrelated to the intensity of NOS2, NOS3, HO-1, or TNF-α gene expression or of NOS2 protein expression. Preload recruitable LV stroke work (PR-LVSW) correlated directly with NOS2 gene expression ( P = 0.001) and inversely with CVF ( P = 0.04). High CVF (>10%) reduced baseline LVSW and PR-LVSW at each level of NOS2 gene expression. In DCM, myocardial fibrosis is unrelated to the intensity of myocardial gene expression of NOS, antioxidative enzymes (HO-1), or cytokines (TNF-α) and blunts NOS2-related recruitment of LV preload reserve.Keywords
This publication has 38 references indexed in Scilit:
- Endomyocardial nitric oxide synthase and the hemodynamic phenotypes of human dilated cardiomyopathy and of athlete's heartCardiovascular Research, 2002
- Effects of nitric oxide synthase inhibition on Basal function and the force-frequency relationship in the normal and failing human heart in vivo.Circulation, 2001
- Lisinopril-Mediated Regression of Myocardial Fibrosis in Patients With Hypertensive Heart DiseaseCirculation, 2000
- Spironolactone Increases Nitric Oxide Bioactivity, Improves Endothelial Vasodilator Dysfunction, and Suppresses Vascular Angiotensin I/Angiotensin II Conversion in Patients With Chronic Heart FailureCirculation, 2000
- Chronic N G -Nitro- l -Arginine Methyl Ester–Induced HypertensionCirculation, 2000
- Angiotensin II Activates Collagen Type I Gene in the Renal Vasculature of Transgenic Mice During Inhibition of Nitric Oxide SynthesisCirculation, 1999
- Heterogeneous Basal Expression of Nitric Oxide Synthase and Superoxide Dismutase Isoforms in Mammalian HeartCirculation Research, 1999
- Nitric oxide synthase expression and role during cardiomyogenesisCardiovascular Research, 1999
- Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heartJournal of the American College of Cardiology, 1998
- Comparative effects of pacing-induced and balloon coronary occlusion ischemia on left ventricular diastolic function in man.Circulation, 1991